Skip to main content
Top
Published in: Calcified Tissue International 1/2018

Open Access 01-01-2018 | Original Research

Illness Perceptions are Associated with Quality of Life in Patients with Fibrous Dysplasia

Authors: B. C. J. Majoor, C. D. Andela, C. R. Quispel, M. Rotman, P. D. S. Dijkstra, N. A. T. Hamdy, A. A. Kaptein, N. M. Appelman-Dijkstra

Published in: Calcified Tissue International | Issue 1/2018

Login to get access

Abstract

Fibrous dysplasia (FD) is a rare bone disorder in which normal bone is replaced by fibrous tissue resulting in pain, deformities, pathological fractures or asymptomatic disease. Illness perceptions are patients’ cognitions and emotions about their illness and its treatment, which may impact on Quality of Life (QoL). Here, we explore illness perceptions in patients with FD compared to other disorders, identify factors associated with illness perceptions and evaluate their relationship with QoL. Ninety-seven out of 138 eligible patients from the LUMC FD cohort completed the Illness Perception Questionnaire-Revised (IPQ-R) and the Short Form-36 (SF-36). Age, Gender, Skeletal Burden Score (SBS), FGF-23 levels, type of FD and SF-36 scores were analysed for an association with illness perceptions. We observed significant (p < 0.01) differences in patients’ illness perceptions between FD subtypes in the domains: identity, timeline acute/chronic and consequences. Patients with craniofacial FD reported to perceive more consequences (p = 0.022). High SBS was associated with perceiving more negative consequences and attributing the cause of FD to psychological factors (p < 0.01), and high FGF-23 levels with attributing more symptoms to the disease and perceiving more consequences (p < 0.01). The IPQ-R domain identity, timeline acute/chronic, timeline cyclical, consequences, emotional representations and treatment control were significantly associated with impairments in QoL. Illness perceptions in patients with FD relate to QoL, differ from those in patients with other disorders, and are associated with disease severity. Identifying and addressing maladaptive illness perceptions may improve quality of life in patients with FD.
Appendix
Available only for authorised users
Literature
1.
go back to reference Weinstein LS, Shenker A, Gejman PV, Merino MJ, Friedman E, Spiegel AM (1991) Activating mutations of the stimulatory G protein in the McCune–Albright syndrome. N Engl J Med 325:1688–1695CrossRefPubMed Weinstein LS, Shenker A, Gejman PV, Merino MJ, Friedman E, Spiegel AM (1991) Activating mutations of the stimulatory G protein in the McCune–Albright syndrome. N Engl J Med 325:1688–1695CrossRefPubMed
2.
go back to reference Kelly MH, Brillante B, Kushner H, Gehron Robey P, Collins MT (2005) Physical function is impaired but quality of life preserved in patients with fibrous dysplasia of bone. Bone 37:388–394CrossRefPubMed Kelly MH, Brillante B, Kushner H, Gehron Robey P, Collins MT (2005) Physical function is impaired but quality of life preserved in patients with fibrous dysplasia of bone. Bone 37:388–394CrossRefPubMed
3.
go back to reference Majoor BCJ, Andela CD, Bruggemann J, van de Sande MAJ, Kaptein AA, Hamdy NAT, Dijkstra PDS, Appelman-Dijkstra NM (2017) Determinants of impaired quality of life in patients with fibrous dysplasia. Orphanet J Rare Dis 12:80CrossRefPubMedPubMedCentral Majoor BCJ, Andela CD, Bruggemann J, van de Sande MAJ, Kaptein AA, Hamdy NAT, Dijkstra PDS, Appelman-Dijkstra NM (2017) Determinants of impaired quality of life in patients with fibrous dysplasia. Orphanet J Rare Dis 12:80CrossRefPubMedPubMedCentral
4.
go back to reference Tiemensma J, Kaptein AA, Pereira AM, Smit JW, Romijn JA, Biermasz NR (2011) Negative illness perceptions are associated with impaired quality of life in patients after long-term remission of Cushing’s syndrome. Eur J Endocrinol 165:527–535CrossRefPubMed Tiemensma J, Kaptein AA, Pereira AM, Smit JW, Romijn JA, Biermasz NR (2011) Negative illness perceptions are associated with impaired quality of life in patients after long-term remission of Cushing’s syndrome. Eur J Endocrinol 165:527–535CrossRefPubMed
5.
go back to reference Scharloo M, Kaptein AA, Weinman J, Hazes JM, Willems LN, Bergman W, Rooijmans HG (1998) Illness perceptions, coping and functioning in patients with rheumatoid arthritis, chronic obstructive pulmonary disease and psoriasis. J Psychosom Res 44:573–585CrossRefPubMed Scharloo M, Kaptein AA, Weinman J, Hazes JM, Willems LN, Bergman W, Rooijmans HG (1998) Illness perceptions, coping and functioning in patients with rheumatoid arthritis, chronic obstructive pulmonary disease and psoriasis. J Psychosom Res 44:573–585CrossRefPubMed
6.
go back to reference Vogel JJ, Godefroy WP, van der Mey AG, le Cessie S, Kaptein AA (2008) Illness perceptions, coping, and quality of life in vestibular schwannoma patients at diagnosis. Otol Neurotol 29:839–845CrossRefPubMed Vogel JJ, Godefroy WP, van der Mey AG, le Cessie S, Kaptein AA (2008) Illness perceptions, coping, and quality of life in vestibular schwannoma patients at diagnosis. Otol Neurotol 29:839–845CrossRefPubMed
7.
go back to reference McAndrew LM, Musumeci-Szabo TJ, Mora PA, Vileikyte L, Burns E, Halm EA, Leventhal EA, Leventhal H (2008) Using the common sense model to design interventions for the prevention and management of chronic illness threats: from description to process. Br J Health Psychol 13:195–204CrossRefPubMed McAndrew LM, Musumeci-Szabo TJ, Mora PA, Vileikyte L, Burns E, Halm EA, Leventhal EA, Leventhal H (2008) Using the common sense model to design interventions for the prevention and management of chronic illness threats: from description to process. Br J Health Psychol 13:195–204CrossRefPubMed
8.
go back to reference Leventhal H, Phillips LA, Burns E (2016) The common-sense model of self-regulation (CSM): a dynamic framework for understanding illness self-management. J Behav Med 39(6):935–946CrossRefPubMed Leventhal H, Phillips LA, Burns E (2016) The common-sense model of self-regulation (CSM): a dynamic framework for understanding illness self-management. J Behav Med 39(6):935–946CrossRefPubMed
9.
go back to reference Petrie KJ, Cameron LD, Ellis CJ, Buick D, Weinman J (2002) Changing illness perceptions after myocardial infarction: an early intervention randomized controlled trial. Psychosom Med 64:580–586CrossRefPubMed Petrie KJ, Cameron LD, Ellis CJ, Buick D, Weinman J (2002) Changing illness perceptions after myocardial infarction: an early intervention randomized controlled trial. Psychosom Med 64:580–586CrossRefPubMed
10.
go back to reference Moss-Morris RW, Weinman J, Petrie KJ, Horne R, Cameron LD, Buick D (2002) The revised illness perception questionnaire (IPQ-R). Psychol Health 17:1–16CrossRef Moss-Morris RW, Weinman J, Petrie KJ, Horne R, Cameron LD, Buick D (2002) The revised illness perception questionnaire (IPQ-R). Psychol Health 17:1–16CrossRef
11.
go back to reference Leventhal HB, Brissette I, Leventhal EA (2003) The common-sense model of self-regulation of health and illness. In: Cameron LD, Leventhal H (eds) The self-regulation of health and illness behaviour. Routledge, London, pp 42–65 Leventhal HB, Brissette I, Leventhal EA (2003) The common-sense model of self-regulation of health and illness. In: Cameron LD, Leventhal H (eds) The self-regulation of health and illness behaviour. Routledge, London, pp 42–65
12.
go back to reference Hagger MSO, Orbell S (2003) A meta-analytic review of the common-sense model of illness representations. Psychol Health 18:141–184CrossRef Hagger MSO, Orbell S (2003) A meta-analytic review of the common-sense model of illness representations. Psychol Health 18:141–184CrossRef
13.
go back to reference Majoor BC, Appelman-Dijkstra NM, Fiocco M, van de Sande MA, Dijkstra PD, Hamdy NA (2016) Outcome of long-term bisphosphonate therapy in McCune–Albright syndrome and polyostotic fibrous dysplasia. J Bone Miner Res 32:264–276CrossRefPubMed Majoor BC, Appelman-Dijkstra NM, Fiocco M, van de Sande MA, Dijkstra PD, Hamdy NA (2016) Outcome of long-term bisphosphonate therapy in McCune–Albright syndrome and polyostotic fibrous dysplasia. J Bone Miner Res 32:264–276CrossRefPubMed
14.
go back to reference Collins MT, Kushner H, Reynolds JC et al (2005) An instrument to measure skeletal burden and predict functional outcome in fibrous dysplasia of bone. J Bone Mineral Res 20:219–226CrossRef Collins MT, Kushner H, Reynolds JC et al (2005) An instrument to measure skeletal burden and predict functional outcome in fibrous dysplasia of bone. J Bone Mineral Res 20:219–226CrossRef
16.
go back to reference Field A (2000) Exploratory factor analysis. Discovering statistics using SPSS. SAGE publications Ltd, London, pp 627–685 Field A (2000) Exploratory factor analysis. Discovering statistics using SPSS. SAGE publications Ltd, London, pp 627–685
17.
go back to reference Tiemensma J, Kaptein AA, Pereira AM, Smit JW, Romijn JA, Biermasz NR (2011) Affected illness perceptions and the association with impaired quality of life in patients with long-term remission of acromegaly. J Clin Endocrinol Metab 96:3550–3558CrossRefPubMed Tiemensma J, Kaptein AA, Pereira AM, Smit JW, Romijn JA, Biermasz NR (2011) Affected illness perceptions and the association with impaired quality of life in patients with long-term remission of acromegaly. J Clin Endocrinol Metab 96:3550–3558CrossRefPubMed
18.
go back to reference van Wilgen CP, van Ittersum MW, Kaptein AA, van Wijhe M (2008) Illness perceptions in patients with fibromyalgia and their relationship to quality of life and catastrophizing. Arthritis Rheum 58:3618–3626CrossRefPubMed van Wilgen CP, van Ittersum MW, Kaptein AA, van Wijhe M (2008) Illness perceptions in patients with fibromyalgia and their relationship to quality of life and catastrophizing. Arthritis Rheum 58:3618–3626CrossRefPubMed
19.
go back to reference Roerink SH, Wagenmakers MA, Wessels JF, Sterenborg RB, Smit JW, Hermus AR, Netea-Maier RT (2015) Persistent self-consciousness about facial appearance, measured with the Derriford appearance scale 59, in patients after long-term biochemical remission of acromegaly. Pituitary 18:366–375CrossRefPubMed Roerink SH, Wagenmakers MA, Wessels JF, Sterenborg RB, Smit JW, Hermus AR, Netea-Maier RT (2015) Persistent self-consciousness about facial appearance, measured with the Derriford appearance scale 59, in patients after long-term biochemical remission of acromegaly. Pituitary 18:366–375CrossRefPubMed
20.
go back to reference Lee JS, FitzGibbon EJ, Chen YR, Kim HJ, Lustig LR, Akintoye SO, Collins MT, Kaban LB (2012) Clinical guidelines for the management of craniofacial fibrous dysplasia. Orphanet J Rare Dis 7(Suppl 1):S2CrossRefPubMedPubMedCentral Lee JS, FitzGibbon EJ, Chen YR, Kim HJ, Lustig LR, Akintoye SO, Collins MT, Kaban LB (2012) Clinical guidelines for the management of craniofacial fibrous dysplasia. Orphanet J Rare Dis 7(Suppl 1):S2CrossRefPubMedPubMedCentral
21.
go back to reference Majoor BC, Peeters-Boef MJ, van de Sande MA, Appelman-Dijkstra NM, Hamdy NA, Dijkstra PD (2016) What is the role of allogeneic cortical strut grafts in the treatment of fibrous dysplasia of the proximal femur? Clin Orthop Relat Res 475:786–795CrossRefPubMedCentral Majoor BC, Peeters-Boef MJ, van de Sande MA, Appelman-Dijkstra NM, Hamdy NA, Dijkstra PD (2016) What is the role of allogeneic cortical strut grafts in the treatment of fibrous dysplasia of the proximal femur? Clin Orthop Relat Res 475:786–795CrossRefPubMedCentral
22.
go back to reference Stanton RP, Ippolito E, Springfield D, Lindaman L, Wientroub S, Leet A (2012) The surgical management of fibrous dysplasia of bone. Orphanet J Rare Dis 7(Suppl 1):S1CrossRefPubMedPubMedCentral Stanton RP, Ippolito E, Springfield D, Lindaman L, Wientroub S, Leet A (2012) The surgical management of fibrous dysplasia of bone. Orphanet J Rare Dis 7(Suppl 1):S1CrossRefPubMedPubMedCentral
23.
go back to reference DiCaprio MR, Enneking WF (2005) Fibrous dysplasia. Pathophysiology, evaluation, and treatment. J Bone Jt Surg Am 87:1848–1864 DiCaprio MR, Enneking WF (2005) Fibrous dysplasia. Pathophysiology, evaluation, and treatment. J Bone Jt Surg Am 87:1848–1864
24.
go back to reference Kaptein AA, Klok T, Moss-Morris R, Brand PL (2010) Illness perceptions: impact on self-management and control in asthma. Curr Opin Allergy Clin Immunol 10:194–199CrossRefPubMed Kaptein AA, Klok T, Moss-Morris R, Brand PL (2010) Illness perceptions: impact on self-management and control in asthma. Curr Opin Allergy Clin Immunol 10:194–199CrossRefPubMed
25.
go back to reference Gibson PG, Coughlan J, Wilson AJ, Abramson M, Bauman A, Hensley MJ, Walters EH (2000) Self-management education and regular practitioner review for adults with asthma. Cochrane Database Syst Rev. doi:10.1002/14651858.CD001117 Gibson PG, Coughlan J, Wilson AJ, Abramson M, Bauman A, Hensley MJ, Walters EH (2000) Self-management education and regular practitioner review for adults with asthma. Cochrane Database Syst Rev. doi:10.​1002/​14651858.​CD001117
26.
go back to reference Kelly MH, Brillante B, Collins MT (2008) Pain in fibrous dysplasia of bone: age-related changes and the anatomical distribution of skeletal lesions. Osteoporos Int 19:57–63CrossRefPubMed Kelly MH, Brillante B, Collins MT (2008) Pain in fibrous dysplasia of bone: age-related changes and the anatomical distribution of skeletal lesions. Osteoporos Int 19:57–63CrossRefPubMed
27.
go back to reference Chapurlat RD, Gensburger D, Jimenez-Andrade JM, Ghilardi JR, Kelly M, Mantyh P (2012) Pathophysiology and medical treatment of pain in fibrous dysplasia of bone. Orphanet J Rare Dis 7(Suppl 1):S3CrossRefPubMedPubMedCentral Chapurlat RD, Gensburger D, Jimenez-Andrade JM, Ghilardi JR, Kelly M, Mantyh P (2012) Pathophysiology and medical treatment of pain in fibrous dysplasia of bone. Orphanet J Rare Dis 7(Suppl 1):S3CrossRefPubMedPubMedCentral
28.
go back to reference Petrie KJ, Jago LA, Devcich DA (2007) The role of illness perceptions in patients with medical conditions. Curr Opin Psychiatry 20:163–167CrossRefPubMed Petrie KJ, Jago LA, Devcich DA (2007) The role of illness perceptions in patients with medical conditions. Curr Opin Psychiatry 20:163–167CrossRefPubMed
Metadata
Title
Illness Perceptions are Associated with Quality of Life in Patients with Fibrous Dysplasia
Authors
B. C. J. Majoor
C. D. Andela
C. R. Quispel
M. Rotman
P. D. S. Dijkstra
N. A. T. Hamdy
A. A. Kaptein
N. M. Appelman-Dijkstra
Publication date
01-01-2018
Publisher
Springer US
Published in
Calcified Tissue International / Issue 1/2018
Print ISSN: 0171-967X
Electronic ISSN: 1432-0827
DOI
https://doi.org/10.1007/s00223-017-0329-5

Other articles of this Issue 1/2018

Calcified Tissue International 1/2018 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.